Insider Trading June 8, 2026 05:31 PM

Five9 CFO Lee Bryan M Executes Multiple Stock Sales Ahead of Analyst Upgrades

Executive divestment coincides with strong Q1 earnings and raised guidance, as Wall Street firms adjust price targets upward.

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
FIVN

Lee Bryan M, Chief Financial Officer of Five9, Inc. (NASDAQ:FIVN), executed a series of stock sales totaling approximately $449,059 across June 4 and June 5, 2026. The transactions involved the sale of 18,131 shares at weighted average prices between $24.16 and $25.69. These sales were primarily structured to cover tax obligations arising from the vesting of restricted stock units, conducted under a pre-established Rule 10b5-1 trading plan and the company's internal sell-to-cover policies. Despite the executive's divestment, Five9 has demonstrated robust financial momentum, with first-quarter results surpassing consensus expectations and management raising annual revenue guidance. This positive momentum has prompted several analyst firms to increase their price targets, reflecting growing confidence in the company's strategic direction.

Five9 CFO Lee Bryan M Executes Multiple Stock Sales Ahead of Analyst Upgrades
FIVN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Executive divestment: CFO Lee Bryan M sold 18,131 shares for ~$449,059 to cover taxes on restricted stock unit vesting, reducing direct holdings to 309,951 shares.
  • Financial momentum: Five9 reported Q1 results beating consensus, with 13% subscription growth accelerating for the second consecutive quarter and raised annual revenue guidance.
  • Analyst upgrades: Major firms including Rosenblatt, Mizuho, Jefferies, and DA Davidson have increased price targets, citing strong earnings, operating leverage, and AI-driven growth.

Lee Bryan M, serving as the Chief Financial Officer for Five9, Inc. (NASDAQ:FIVN), recently completed a sequence of stock sales that collectively generated approximately $449,059. The transactions occurred over two trading days, June 4 and June 5, 2026, and involved the disposition of 18,131 shares of the company's common stock. The weighted average prices for these shares ranged from $24.16 to $25.69. Following these transactions, the CFO's direct holdings in Five9 stand at 309,951 shares.

The sales on June 4 were executed through multiple distinct transactions. Mr. Lee first sold 4,794 shares at a weighted average price of $24.16, with individual transaction prices varying between $23.60 and $24.60. Subsequently, 6,107 shares were sold at a weighted average price of $25.13, with individual prices ranging from $24.62 to $25.62. A third transaction on the same day involved the sale of 1,406 shares at a weighted average price of $25.69, with individual prices spanning from $25.64 to $25.83. These three transactions were conducted under a Rule 10b5-1 trading plan that was adopted on September 3, 2025. The primary purpose of these sales was to cover taxes associated with the vesting of restricted stock units.

Also on June 4, Mr. Lee executed an additional sale of 4,313 shares at a weighted average price of $24.81. This specific transaction was also designated for tax withholding purposes upon the vesting of restricted stock units. It was processed in accordance with Five9, Inc.'s established "Corporations Policy" for sell-to-cover withholding. On June 5, the executive completed one final transaction, selling 1,511 shares at a price of $24.25 per share. This sale was also facilitated under the Rule 10b5-1 trading plan.

The recent stock activity occurs against a backdrop of positive financial performance for Five9. The company reported first-quarter earnings and revenue that exceeded consensus expectations. A notable 13% growth in subscriptions was recorded, marking the second consecutive quarter of acceleration in this metric. Management expressed confidence in continued performance, leading to an increase in annual revenue guidance based on the first-quarter upside. This represents a shift from previous years' guidance practices.

Analyst firms have responded to these developments with upward adjustments to their price targets. Rosenblatt increased its price target to $29, maintaining a Buy rating, citing an earnings beat and early operating leverage. Mizuho raised its target to $32, maintaining an Outperform rating, and highlighted a solid first-quarter performance along with faster backlog conversion. Jefferies adjusted its target to $21, acknowledging revenue and earnings beats, while DA Davidson increased its target to $22, noting strong AI-driven growth. These adjustments reflect a growing confidence in Five9's strategic direction and financial health.

While the executive sales occurred at prices above the current market level, the stock has since declined to $23.15, representing a drop of approximately 10% over the past week. Despite this recent pullback, shares remain up 17% year-to-date. According to InvestingPro analysis, Five9 appears significantly undervalued at current levels, trading well below its Fair Value estimate. This positions the stock on the list of most undervalued stocks, suggesting potential upside for investors who monitor valuation metrics closely.

Risks

  • Stock price volatility: The shares have declined ~10% over the past week following the executive sales, indicating potential short-term downward pressure despite long-term valuation metrics.
  • Guidance reliance: The raised annual revenue guidance is based on first-quarter upside, which may not be sustained if market conditions or competitive dynamics shift.
  • Valuation divergence: While the stock is considered undervalued by some models, the recent price decline suggests a disconnect between current market pricing and fundamental estimates.

More from Insider Trading

UDR Chief Executive Sells $3.1 Million in Shares Amid Strong Quarterly Earnings Jun 8, 2026 Hycroft Mining Executive Unloads Shares Amid Strategic Expansion Jun 8, 2026 Guardant Health Co-CEO Helmy Eltoukhy Offloads $12.6M in Shares Amid Stock Rally Jun 8, 2026 Guardant Health CFO Michael Bell Executes $257,240 Share Sale Amid Analyst Optimism Jun 8, 2026 Hycroft Mining Executive Sells Shares Amidst Operational Expansion and Valuation Debates Jun 8, 2026